2022
DOI: 10.1021/acsinfecdis.1c00432
|View full text |Cite
|
Sign up to set email alerts
|

Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach

Abstract: Mycobacterium abscessus has emerged as a challenging threat to individuals with cystic fibrosis, particularly children. It is often impossible to treat the infection caused by this mycobacterium due to its intrinsic antibiotic resistance leading to lung malfunction and eventually death. Therefore, there is an urgent need to develop new drugs against novel targets in M. abscessus to overcome drug resistance and subsequent treatment failure. In this study, SAICAR synthase (PurC) from Mycobacterium abscessus (Mab… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 53 publications
(111 reference statements)
0
10
0
Order By: Relevance
“…Substrate/product-based inhibitors of PAICS homologues have been synthesized in the past as tools in enzymatic analysis 10 and recent efforts have been made to develop inhibitors of prokaryotic PAICS homologues to combat antibiotic resistance. 11 …”
Section: Introductionmentioning
confidence: 99%
“…Substrate/product-based inhibitors of PAICS homologues have been synthesized in the past as tools in enzymatic analysis 10 and recent efforts have been made to develop inhibitors of prokaryotic PAICS homologues to combat antibiotic resistance. 11 …”
Section: Introductionmentioning
confidence: 99%
“…Structures of M. tuberculosis PurN, PurH, and PurF, which are involved in de novo purine synthesis, revealed structural distinctions from the equivalent human enzymes, suggesting that specific inhibitors could be designed against these proteins [57-59]. Mycobacterium abscessus PurC is also structurally distinct from the human ortholog, and PurC inhibitors that prevent M. tuberculosis growth in vitro were recently described [60]. An indazole sulfonamide compound that inhibits GuaB2 was cidal against replicating M. tuberculosis in vitro but lacked activity in infected mice due to either low drug concentration in lung lesions, slower growth of M. tuberculosis in chronically infected mice, or high levels of guanine in host tissues that antagonize the drug [61].…”
Section: Discussionmentioning
confidence: 99%
“…From a structural perspective, both the FtsZ nucleotide and the allosteric binding sites show annex cavities available for fragment binding ( Figure 1 and Figure 6 ). This suggests the possibility of applying HT X-ray crystallographic screening of fragment libraries and further structure-guided fragment-based approaches [ 82 ] to develop new FtsZ inhibitors. Several NMR methods may be also applied to search for FtsZ-binding fragments, including ligand-based fluorine NMR screening [ 83 ].…”
Section: Outlook For Other Methods Vs and Machine Learning Approaches...mentioning
confidence: 99%